[HTML][HTML] Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making
AW Bradbury, DJ Adam, J Bell, JF Forbes… - Journal of vascular …, 2010 - Elsevier
BACKGROUND: An intention-to-treat analysis of the Bypass versus Angioplasty in Severe
Ischaemia of the Leg (BASIL) trial showed that in patients with severe lower limb ischemia
(SLI) due to infrainguinal disease who survived for 2 years after intervention, initial
randomization to a bypass surgery (BSX)-first vs balloon angioplasty (BAP)-first
revascularization strategy was associated with improvements in subsequent overall survival
(OS) and amputation-free survival (AFS) of about 7 and 6 months, respectively. This study …
Ischaemia of the Leg (BASIL) trial showed that in patients with severe lower limb ischemia
(SLI) due to infrainguinal disease who survived for 2 years after intervention, initial
randomization to a bypass surgery (BSX)-first vs balloon angioplasty (BAP)-first
revascularization strategy was associated with improvements in subsequent overall survival
(OS) and amputation-free survival (AFS) of about 7 and 6 months, respectively. This study …
[CITATION][C] BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision …
AW Bradbury - J Vasc Surg, 2010